Insider Trading activities of Pharmaceutical Product Development Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmaceutical Product Development Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmaceutical Product Development Inc since year 2005. Table 2 shows the detailed insider transactions of Pharmaceutical Product Development Inc since 2005. The reporting company's ticker symbol is PPDI. The reporting company's CIK number is 1003124.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $231,428,718.
The total value of stock option exercises since 2005 is $26,528,406.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pharmaceutical Product Development Inc (PPDI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-05 0 $0 118,835 $3,582,838 118,835 $2,410,194
2011-03 0 $0 16,562 $457,524 16,562 $253,066
2011-02 0 $0 80,664 $2,214,282 88,945 $1,891,965
2010-11 0 $0 51,753 $1,330,677 51,753 $1,137,530
2010-08 0 $0 26,726 $671,357 0 $0
2010-03 0 $0 0 $0 16,000 $72,000
2009-12 0 $0 0 $0 32,000 $458,240
2009-04 0 $0 0 $0 16,000 $100,000
2008-08 0 $0 30,297 $1,252,779 30,297 $1,048,275
2008-07 0 $0 0 $0 20,000 $286,300
2008-05 0 $0 321,828 $13,915,095 28,000 $414,640
2008-03 0 $0 0 $0 16,000 $100,000
2008-02 0 $0 109,986 $5,158,590 77,666 $1,875,947
2007-11 0 $0 6,000 $252,281 6,000 $78,000
2007-08 0 $0 74,808 $2,896,201 16,000 $95,520
2007-07 0 $0 299,355 $11,487,189 5,458 $129,845
2007-06 0 $0 325,182 $11,965,832 20,000 $692,400
2007-05 0 $0 947,632 $32,961,504 145,501 $2,541,179
2007-04 0 $0 226,199 $7,736,991 0 $0
2007-03 0 $0 301,834 $9,505,347 16,000 $0
2007-02 0 $0 472,699 $15,849,813 134,500 $2,410,475
2006-11 0 $0 305,724 $9,358,739 158,812 $2,590,187
2006-10 0 $0 93,188 $3,290,046 93,188 $1,473,436
2006-06 0 $0 47,500 $1,754,460 0 $0
2006-05 0 $0 1,041,745 $38,094,922 250,000 $3,738,600
2006-04 0 $0 0 $0 5,000 $24,400
2006-03 0 $0 41,000 $1,428,276 0 $0
2006-02 0 $0 92,334 $6,271,107 92,334 $2,706,207
2005-11 0 $0 29,000 $1,697,863 0 $0
2005-08 0 $0 20,000 $1,162,120 0 $0
2005-07 0 $0 768,378 $45,974,660 0 $0
2005-05 0 $0 15,000 $698,100 0 $0
2005-04 0 $0 10,000 $460,125 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pharmaceutical Product Development Inc insiders (PPDI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-05-27 Colvin Paul (EVP--Clinical Development) Sale 5,659 28.70 162,413
2011-05-27 Colvin Paul (EVP--Clinical Development) Option Ex 5,659 20.20 114,283
2011-05-26 Colvin Paul (EVP--Clinical Development) Sale 100 28.70 2,870
2011-05-26 Colvin Paul (EVP--Clinical Development) Option Ex 100 19.94 1,994
2011-05-20 Colvin Paul (EVP--Clinical Development) Sale 600 29.01 17,406
2011-05-20 Colvin Paul (EVP--Clinical Development) Option Ex 600 20.20 12,117
2011-05-03 Hartman Judd (General Counsel) Sale 112,476 30.23 3,400,149
2011-05-03 Hartman Judd (General Counsel) Option Ex 112,476 20.29 2,281,800
2011-03-01 Magnuson Terry (Director) Sale 8,281 27.70 229,383
2011-03-01 Magnuson Terry (Director) Option Ex 8,281 15.28 126,533
2011-03-01 Frank Fred (Director) Sale 8,281 27.55 228,141
2011-03-01 Frank Fred (Director) Option Ex 8,281 15.28 126,533
2011-02-28 Wilkinson Michael O. (Chief Information Officer) Sale 21,667 28.19 610,792
2011-02-28 Wilkinson Michael O. (Chief Information Officer) Option Ex 21,667 23.10 500,399
2011-02-28 Grange David L (Chief Executive Officer) Sale 34,501 26.00 897,026
2011-02-28 Grange David L (Chief Executive Officer) Option Ex 34,501 20.45 705,545
2011-02-24 Mcneill John A Jr (Director) Option Ex 8,281 15.28 126,533
2011-02-14 Wilkinson Michael O. (Chief Information Officer) Sale 24,496 28.84 706,464
2011-02-14 Wilkinson Michael O. (Chief Information Officer) Option Ex 24,496 22.84 559,488
2010-11-03 Grange David L (Chief Executive Officer) Sale 51,380 25.71 1,320,979
2010-11-03 Grange David L (Chief Executive Officer) Option Ex 51,380 21.98 1,129,332
2010-11-02 Grange David L (Chief Executive Officer) Sale 373 26.00 9,698
2010-11-02 Grange David L (Chief Executive Officer) Option Ex 373 21.98 8,198
2010-08-09 Mario Ernest (Director) Sale 26,726 25.12 671,357
2010-03-23 Mcneill John A Jr (Director) Option Ex 16,000 4.50 72,000
2009-12-17 Mario Ernest (Director) Option Ex 32,000 14.32 458,240
2009-04-28 Mcneill John A Jr (Director) Option Ex 16,000 6.25 100,000
2008-08-07 Grange David L (Director) Sale 20,198 41.35 835,186
2008-08-07 Grange David L (Director) Option Ex 20,198 34.60 698,850
2008-07-23 Mario Ernest (Director) Option Ex 20,000 14.32 286,300
2008-05-30 Mcneill John A Jr (Director) Sale 5,600 44.03 246,545
2008-05-29 Mcneill John A Jr (Director) Sale 63,498 44.02 2,795,662
2008-05-28 Klema Cathy (Director) Sale 8,000 43.60 348,760
2008-05-28 Klema Cathy (Director) Option Ex 8,000 13.58 108,640
2008-05-28 Mcneill John A Jr (Director) Sale 216 44.00 9,504
2008-05-27 Mcneill John A Jr (Director) Sale 30,236 44.04 1,331,744
2008-05-21 Eshelman Fredric N (CEO) Sale 14,000 43.56 609,854
2008-05-20 Eshelman Fredric N (CEO) Sale 96,000 42.64 4,096,398
2008-05-19 Eshelman Fredric N (CEO) Sale 40,000 43.00 1,719,840
2008-05-02 Hartman Judd (General Counsel) Sale 20,000 42.62 852,480
2008-05-02 Hartman Judd (General Counsel) Option Ex 20,000 15.30 306,000
2008-03-13 Mario Ernest (Director) Option Ex 16,000 6.25 100,000
2008-02-28 Covington Paul S (Executive Vice President) Sale 36,666 46.88 1,718,191
2008-02-28 Covington Paul S (Executive Vice President) Option Ex 36,666 34.11 1,250,677
2008-02-28 Mcneill John A Jr (Director) Sale 6,304 47.05 296,603
2008-02-28 Mcneill John A Jr (Director) Option Ex 16,000 5.97 95,520
2008-02-26 Covington Paul S (Executive Vice President) Sale 25,000 46.94 1,173,375
2008-02-26 Covington Paul S (Executive Vice President) Option Ex 25,000 21.19 529,750
2008-02-26 Mcneill John A Jr (Director) Sale 5,596 47.18 263,991
2008-02-25 Mcneill John A Jr (Director) Sale 9,950 46.90 466,655
2007-11-27 Wilkinson Peter J (VP of Fin./Chief Acctg. Off.) Sale 6,000 42.05 252,281
2007-11-27 Wilkinson Peter J (VP of Fin./Chief Acctg. Off.) Option Ex 6,000 13.00 78,000
2007-08-29 Covington Paul S (Executive Vice President) Sale 9,045 35.09 317,389
2007-08-17 Wilkinson Peter J (VP of Fin./Chief Acctg. Off.) Sale 1,287 36.75 47,301
2007-08-09 Mario Ernest (Director) Sale 16,000 38.69 619,088
2007-08-09 Mario Ernest (Director) Option Ex 16,000 5.97 95,520
2007-08-09 Mcneill John A Jr (Director) Sale 30,411 39.54 1,201,403
2007-07-26 Grange David L (Director) Sale 5,458 33.76 184,262
2007-07-26 Grange David L (Director) Option Ex 5,458 23.79 129,845
2007-07-16 Eshelman Fredric N (CEO) Sale 83,334 38.47 3,220,034
2007-07-02 Eshelman Fredric N (CEO) Sale 83,333 38.31 3,190,613
2007-06-19 Eshelman Fredric N (CEO) Sale 100 36.58 3,658
2007-06-18 Eshelman Fredric N (CEO) Sale 83,234 36.84 3,062,983
2007-06-01 Baddour Linda (Chief Financial Officer) Sale 20,000 36.82 736,480
2007-06-01 Baddour Linda (Chief Financial Officer) Option Ex 20,000 34.62 692,400
2007-06-01 Eshelman Fredric N (CEO) Sale 83,333 36.95 3,068,574
2007-05-29 Covington Paul S (Executive Vice President) Sale 40,084 35.21 1,411,237
2007-05-29 Covington Paul S (Executive Vice President) Option Ex 38,334 18.24 699,403
2007-05-25 Baddour Linda (Chief Financial Officer) Sale 1,300 35.40 46,020
2007-05-23 Klema Cathy (Director) Sale 12,000 35.48 425,700
2007-05-23 Klema Cathy (Director) Option Ex 12,000 12.81 153,720
2007-05-23 Baddour Linda (Chief Financial Officer) Sale 6,757 35.30 238,522
2007-05-23 Mario Ernest (Director) Sale 100,000 35.37 3,536,600
2007-05-22 Mario Ernest (Director) Sale 34,120 35.33 1,205,357
2007-05-21 Mario Ernest (Director) Sale 65,880 35.32 2,326,552
2007-05-18 Hartman Judd (General Counsel) Sale 40,500 34.94 1,415,151
2007-05-18 Hartman Judd (General Counsel) Option Ex 40,500 14.45 585,346
2007-05-18 Mario Ernest (Director) Sale 100,000 34.79 3,478,700
2007-05-17 Mario Ernest (Director) Sale 45,552 34.52 1,572,272
2007-05-14 Eshelman Fredric N (CEO) Sale 83,334 33.77 2,804,669
2007-05-08 Baddour Linda (Chief Financial Officer) Sale 16,751 34.47 577,406
2007-05-08 Baddour Linda (Chief Financial Officer) Option Ex 16,751 21.19 354,953
2007-05-08 Mario Ernest (Director) Sale 9,605 34.51 331,468
2007-05-07 Mario Ernest (Director) Sale 100,000 34.68 3,467,799
2007-05-04 Shannon Colin (EVP, Global Clinical Ops) Sale 9,667 35.14 339,746
2007-05-04 Shannon Colin (EVP, Global Clinical Ops) Option Ex 9,667 15.43 149,161
2007-05-03 Baddour Linda (Chief Financial Officer) Sale 41,982 34.92 1,466,221
2007-05-03 Baddour Linda (Chief Financial Officer) Option Ex 28,249 21.19 598,596
2007-05-01 Eshelman Fredric N (CEO) Sale 83,333 35.08 2,925,256
2007-04-16 Eshelman Fredric N (CEO) Sale 83,333 34.51 2,876,029
2007-04-02 Eshelman Fredric N (CEO) Sale 83,333 33.59 2,798,988
2007-03-19 Eshelman Fredric N (CEO) Sale 83,334 31.72 2,636,653
2007-03-01 Eshelman Fredric N (CEO) Sale 83,333 31.37 2,611,801
2007-03-01 Mcneill John A Jr (Director) Option Ex 16,000 .00 0
2007-02-26 Eshelman Fredric N (CEO) Sale 83,333 33.22 2,748,572
2007-02-20 Eshelman Fredric N (CEO) Sale 83,333 33.44 2,783,434
2007-02-13 Magnuson Terry (Director) Sale 16,000 33.78 540,560
2007-02-13 Magnuson Terry (Director) Option Ex 16,000 10.74 171,840
2007-02-09 Shannon Colin (EVP, Global Clinical Ops) Sale 32,500 34.14 1,109,712
2007-02-09 Shannon Colin (EVP, Global Clinical Ops) Option Ex 32,500 21.19 688,675
2007-02-09 Grange David L (Director) Sale 6,000 34.14 204,870
2007-02-09 Grange David L (Director) Option Ex 6,000 15.06 90,360
2007-02-09 Baddour Linda (Chief Financial Officer) Sale 80,000 34.14 2,724,905
2007-02-09 Baddour Linda (Chief Financial Officer) Option Ex 80,000 18.24 1,459,600
2006-11-10 Baddour Linda (Chief Financial Officer) Sale 62,979 31.82 2,000,190
2006-11-10 Baddour Linda (Chief Financial Officer) Option Ex 62,979 13.36 841,714
2006-11-02 Davenport Fred B Jr (President) Sale 97,733 29.95 2,920,224
2006-11-02 Davenport Fred B Jr (President) Option Ex 95,833 18.24 1,748,473
2006-10-24 Baddour Linda (Chief Financial Officer) Sale 22,021 35.00 770,735
2006-10-24 Baddour Linda (Chief Financial Officer) Option Ex 22,021 11.98 263,811
2006-10-20 Shannon Colin (EVP, Global Clinical Ops) Sale 71,167 35.40 2,519,311
2006-10-20 Shannon Colin (EVP, Global Clinical Ops) Option Ex 71,167 17.00 1,209,625
2006-06-01 Mcneill John A Jr (Director) Sale 47,500 36.94 1,754,460
2006-05-31 Mcneill John A Jr (Director) Sale 20,000 36.62 732,500
2006-05-24 Grange David L (Director) Sale 10,000 36.24 362,400
2006-05-24 Grange David L (Director) Option Ex 10,000 15.06 150,600
2006-05-23 Mcneill John A Jr (Director) Sale 9,500 37.30 354,350
2006-05-22 Davenport Fred B Jr (President) Sale 160,000 36.49 5,837,920
2006-05-22 Davenport Fred B Jr (President) Option Ex 160,000 14.95 2,392,000
2006-05-22 Mcneill John A Jr (Director) Sale 19,000 36.54 694,260
2006-05-16 Eshelman Fredric N (CEO) Sale 147,000 36.43 5,350,205
2006-05-15 Eshelman Fredric N (CEO) Sale 253,000 36.82 9,296,128
2006-04-10 Mario Ernest (Director) Option Ex 5,000 4.88 24,400
2006-03-01 Mcneill John A Jr (Director) Sale 41,000 34.84 1,428,276
2006-02-27 Klema Cathy (Director) Sale 4,000 70.09 280,360
2006-02-27 Klema Cathy (Director) Option Ex 4,000 31.64 126,560
2006-02-24 Baddour Linda (Chief Financial Officer) Sale 15,000 69.70 1,045,575
2006-02-24 Baddour Linda (Chief Financial Officer) Option Ex 15,000 26.01 390,150
2006-02-23 Covington Paul S (Executive Vice President) Sale 25,834 69.36 1,791,897
2006-02-23 Covington Paul S (Executive Vice President) Option Ex 25,834 34.29 885,847
2006-02-15 Davenport Fred B Jr (President) Sale 30,000 66.12 1,983,750
2006-02-15 Davenport Fred B Jr (President) Option Ex 30,000 28.16 844,800
2006-02-14 Davenport Fred B Jr (President) Sale 17,500 66.83 1,169,525
2006-02-14 Davenport Fred B Jr (President) Option Ex 17,500 26.22 458,850
2005-11-10 Mario Ernest (Director) Sale 29,000 58.55 1,697,863
2005-08-24 Mario Ernest (Director) Sale 20,000 58.11 1,162,120
2005-07-25 Mario Ernest (Director) Sale 1,000 59.37 59,370
2005-07-22 Eshelman Fredric N (CEO) Sale 72,548 59.73 4,332,940
2005-07-21 Eshelman Fredric N (CEO) Sale 327,452 59.84 19,609,775
2005-07-20 Mario Ernest (Director) Sale 25,000 58.76 1,468,925
2005-05-03 Mario Ernest (Director) Sale 15,000 46.54 698,100
2005-04-29 Mario Ernest (Director) Sale 1,619 46.00 74,474
2005-04-28 Mario Ernest (Director) Sale 8,381 46.02 385,651

Insider trading activities including stock purchases, stock sales, and option exercises of PPDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmaceutical Product Development Inc (symbol PPDI, CIK number 1003124) see the Securities and Exchange Commission (SEC) website.